New hope for abdominal cancer patients: targeted chemo combo shows promise
NCT ID NCT01061515
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This early-phase study tests a new way to deliver chemotherapy directly into the abdomen for people whose appendix or colon cancer has spread to the lining of the belly. After surgery to remove visible tumors, participants receive a combination of drugs: one given through a port in the belly, plus two others by mouth and vein. The goal is to find the safest dose and see if this approach can help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.